title: Diffuse Hemorrhagic Brain Metastases in an ALK Fusion Positive Patient on Crizotinib.
authors.affiliation: University Health Network, Department of Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
authors.forename: Kevin
authors.initials: K
authors.lastname: Jao
authors.forename: Pascale
authors.initials: P
authors.lastname: Tomasini
authors.forename: Catherine
authors.initials: C
authors.lastname: Labbe
authors.forename: Mark
authors.initials: M
authors.lastname: Doherty
authors.forename: Frances A
authors.initials: FA
authors.lastname: Shepherd
mesh_terms: D001932:Brain Neoplasms / Q000532:radiotherapy / Q000556:secondary*; D000077547:Crizotinib; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*
chemical_list: D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D000077547:Crizotinib